REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22/09/2025
Voltar para busca
Dado oficial do USPTO
CYCAT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
23/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
14/09/2019
Data de registro
22/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/09/2020
Última transação
23/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Planegg, DE
Examinador
POWERS, ALEXANDER
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MorphoSys AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Antibodies for scientific purposes and not for medical or veterinary use; Monoclonal antibodies for diagnostic use and not for medical or veterinary use; Biochemicalsmonoclonal antibodies for scientific or research use; Tagged antibodies for scientific and laboratory use; immunological antibodies not for medical use; Reagents for use in the development of monoclonal antibodies not for medical or veterinary purposes; biological and biotechnological products used in industry and scienceantibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; biological preparations for laboratoriesfor diagnosticsfor analysis and environmental analysisother than for medical or veterinary use
Classe 5
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; diagnostic antibodies for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical and veterinary purposes for the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; biological preparations for medical and veterinary purposesantibodies sold as a component ingredient of pharmaceuticals
Classe 42
Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological servicesscientific researchanalysistesting services in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; biological research; clinical research in connection with the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/03/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
22/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/06/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/06/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
29/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/12/2019
GNRT
NON-FINAL ACTION E-MAILED
18/12/2019
CNRT
NON-FINAL ACTION WRITTEN
18/12/2019
DOCK
ASSIGNED TO EXAMINER
15/12/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
22/11/2019
ALIE
ASSIGNED TO LIE
21/11/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
17/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/09/2019
NWAP
NEW APPLICATION ENTERED
18/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CYCAT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.